TVTX
Travere Therapeutics Inc
52.00$
-2.6%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -159.4% | -156.4% | -287.6% | -74.4% | -67.6% | -47.8% | -51.6% | 4.4% | 8.7% | 46.8% | -31.7% | 34.2% | 15.7% | |
| 30.9% | 26.3% | 23.9% | 19.1% | 17.9% | 16.2% | 15.7% | 12.2% | 9.6% | 14.0% | 19.8% | 2.5% | 10.7% | |
| 30.5% | 18.1% | 23.6% | 18.3% | 12.8% | 12.3% | 14.1% | 9.3% | 6.8% | 8.8% | 12.7% | 12.8% | 10.3% | |
| -13.2% | 15.8% | -7.1% | -112.2% | -10.7% | 9.9% | -29.0% | -4.9% | -22.6% | 40.6% | -35.5% | 29.3% | 3.4% | |
| 0.0% | 12.3% | 15.6% | 22.2% | 13.0% | 12.8% | 14.4% | 0.2% | 0.1% | 14.5% | 17.4% | 13.1% | 10.7% | |
| 359.4% | -37.6% | 253.5% | 52.9% | 73.3% | -107.4% | 50.5% | 4.2% | 52.5% | -80.8% | 16.9% | -121.6% | -34.3% | |
| – | – | – | – | – | – | – | – | -41.8% | 0.0% | – | – | – | |
| -1.7% | 0.3% | -1.3% | 1.4% | 0.1% | 186.0% | 4.5% | 1.3% | -39.6% | 20.6% | 3.3% | 110.6% | 25.9% | |
| 197.8% | -191.0% | -36.1% | -20.3% | 6.5% | 29.6% | 4.1% | 11.6% | 21.7% | -13.8% | -11.5% | 23.2% | 7.2% | |
| -159.4% | -168.7% | -303.3% | -96.5% | -80.6% | -60.5% | -66.0% | 4.1% | 8.6% | 32.2% | -49.2% | 34.2% | 8.7% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.